(January 19, 2021 – Bethesda, MD) Today, the Bladder Cancer Advocacy Network (BCAN) announced that Elizabeth Plimack, MD, MS of Fox Chase Cancer Center has agreed to serve as the new Chairperson of its Scientific Advisory Board. BCAN’s Scientific Advisory Board (SAB) is composed of distinguished leading academic urologists, oncologists,
Bladder Cancer News
American Cancer Society Report Indicates Increased Bladder Cancer Cases in 2021
(January 13, 2021, Bethesda, MD) Yesterday’s release of the annual American Cancer Society’s (ACS’s) Facts and Figures report indicates that among an expected decline in some cancers, cases of bladder cancer are expected to increase in 2021. According to the ACS, an estimated 83,720 people in the United States will
BCAN Ranked as a Top Charity with a 4-Star Ranking for Seventh Consecutive Year
January 8, 2021 – Bethesda, Maryland – The Bladder Cancer Advocacy Network’s (BCAN’s) strong financial health and commitment to accountability and transparency have earned it a seventh consecutive 4-star rating from Charity Navigator, America’s largest independent charity evaluator. This award puts BCAN in the top seven percent of all charities.
BCAN Announces the 2021 Bladder Cancer Young Investigator Awards
$50,000 awards support the next generation of bladder cancer researchers (January 5, 2021, Bethesda, MD) Today, the Bladder Cancer Advocacy Network (BCAN) announced that it is accepting applications for our 2021 Young Investigator Awards (YIAs). These awards support the professional development of outstanding early career research scientists and clinical cancer
BCAN Applauds Bill to Provide Long-Overdue Help to Veteran Bladder Cancer Patients
(December 11, 2020 – Bethesda, MD) The Bladder Cancer Advocacy Network (BCAN) is pleased that today, the U.S. Senate voted overwhelmingly to approve the National Defense Authorization Act (NDAA) which contains a critical provision that will help veterans who were exposed to Agent Orange and later developed bladder cancer. “By
BCAN to Grant First-Ever Multiple Bladder Cancer Research Innovation Awards in 2021
December 2, 2020 | Bethesda, MD – The Bladder Cancer Advocacy Network (BCAN) is pleased to announce that for the first time ever, it will offer two Bladder Cancer Research Innovation Awards in 2021. These awards will support the work of two experienced investigators with novel and creative projects designed
Bladder Cancer Advocacy Network Welcomes Duncan Alexander to Its Board of Directors
(November 19, 2020) Bethesda, MD – The Bladder Cancer Advocacy Network (BCAN) is pleased to announce that Duncan Alexander has been elected to its Board of Directors. “Mr. Alexander has been a leader in the business community and brings valued expertise to the Board in addition to his history of
Statement on Planned Merck BCG Production Facility to Expand Capacity
October 14, 2020 From Andrea Maddox-Smith, CEO: Today’s news that Merck has announced construction of a new manufacturing facility to significantly expand its production capacity for TICE® BCG is welcome news for bladder cancer patients. We appreciate Merck’s commitment to increase the supply of a treatment that is in such
Bladder Cancer Advocacy Network Statement on Golfer John Daly’s Bladder Cancer Diagnosis
(September 11. 2020 BETHESDA, MD) – The Bladder Cancer Advocacy Network (BCAN) was saddened to learn of the bladder cancer diagnosis of professional golfer John Daly. According to an interview with the Golf Channel, Mr. Daly stated that he had recently been suffering from back pains and said these issues
Current Information About the BCG Shortage
January 2021 Last year, BCAN and its partners shared a message regarding the global shortage of Merck’s TICE BCG due to an increasing global demand for the product. Merck, the sole manufacturer globally since 2012, approved plans to construct a new manufacturing facility to significantly expand production capacity for TICE®
